SGLT2 inhibition suppresses glioblastoma cell proliferation via AMPK activation and mTOR-dependent reduction of protein synthesis under glucose starvationTakeyoshi Eda(Niigata University), Manabu Natsumeda(Niigata University)Research SquareMarch 16, 202610.21203/rs.3.rs-9055004/v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersThe dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma|Cancer Letters|2017|68Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high‐MYC medulloblastoma|Neuropathology|2019|11Novel Repositioning Therapy for Drug-Resistant Glioblastoma: <i>In</i> <i>vivo</i> Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide|Preprints.org|2021|1